These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22826156)

  • 21. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy.
    Morris A; Creasman J; Turner J; Luce JM; Wachter RM; Huang L
    Am J Respir Crit Care Med; 2002 Aug; 166(3):262-7. PubMed ID: 12153955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjusting for Confounding in Early Postlaunch Settings: Going Beyond Logistic Regression Models.
    Schmidt AF; Klungel OH; Groenwold RH;
    Epidemiology; 2016 Jan; 27(1):133-42. PubMed ID: 26436519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cautionary note concerning the use of stabilized weights in marginal structural models.
    Talbot D; Atherton J; Rossi AM; Bacon SL; Lefebvre G
    Stat Med; 2015 Feb; 34(5):812-23. PubMed ID: 25410264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology.
    Bodnar LM; Davidian M; Siega-Riz AM; Tsiatis AA
    Am J Epidemiol; 2004 May; 159(10):926-34. PubMed ID: 15128604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A sequential Cox approach for estimating the causal effect of treatment in the presence of time-dependent confounding applied to data from the Swiss HIV Cohort Study.
    Gran JM; Røysland K; Wolbers M; Didelez V; Sterne JA; Ledergerber B; Furrer H; von Wyl V; Aalen OO
    Stat Med; 2010 Nov; 29(26):2757-68. PubMed ID: 20803557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Missing data in the exposure of interest and marginal structural models: a simulation study based on the Framingham Heart Study.
    Shortreed SM; Forbes AB
    Stat Med; 2010 Feb; 29(4):431-43. PubMed ID: 20025082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fitting marginal structural models: estimating covariate-treatment associations in the reweighted data set can guide model fitting.
    Pullenayegum EM; Lam C; Manlhiot C; Feldman BM
    J Clin Epidemiol; 2008 Sep; 61(9):875-81. PubMed ID: 18486447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive cross-validation for the choice of linear mixed-effects models with application to data from the Swiss HIV Cohort Study.
    Braun J; Held L; Ledergerber B
    Biometrics; 2012 Mar; 68(1):53-61. PubMed ID: 21732925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of highly active antiretroviral therapy on the molecular epidemiology of newly diagnosed HIV infections.
    Ambrosioni J; Junier T; Delhumeau C; Calmy A; Hirschel B; Zdobnov E; Kaiser L; Yerly S;
    AIDS; 2012 Oct; 26(16):2079-86. PubMed ID: 23052354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The alarming problems of confounding equivalence using logistic regression models in the perspective of causal diagrams.
    Yu Y; Li H; Sun X; Su P; Wang T; Liu Y; Yuan Z; Liu Y; Xue F
    BMC Med Res Methodol; 2017 Dec; 17(1):177. PubMed ID: 29281984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Causal inference in survival analysis using longitudinal observational data: Sequential trials and marginal structural models.
    Keogh RH; Gran JM; Seaman SR; Davies G; Vansteelandt S
    Stat Med; 2023 Jun; 42(13):2191-2225. PubMed ID: 37086186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simulating longitudinal data from marginal structural models using the additive hazard model.
    Keogh RH; Seaman SR; Gran JM; Vansteelandt S
    Biom J; 2021 Oct; 63(7):1526-1541. PubMed ID: 33983641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marginal structural models as a tool for standardization.
    Sato T; Matsuyama Y
    Epidemiology; 2003 Nov; 14(6):680-6. PubMed ID: 14569183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Causality and confounding in epidemiology].
    Stang A
    Gesundheitswesen; 2011 Dec; 73(12):884-7. PubMed ID: 22193897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Longitudinal Studies With Repeated Outcome Measures: Adjusting for Time-Dependent Confounding Using Conventional Methods.
    Keogh RH; Daniel RM; VanderWeele TJ; Vansteelandt S
    Am J Epidemiol; 2018 May; 187(5):1085-1092. PubMed ID: 29020128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data.
    Rudin C; Spaenhauer A; Keiser O; Rickenbach M; Kind C; Aebi-Popp K; Brinkhof MW; ;
    HIV Med; 2011 Apr; 12(4):228-35. PubMed ID: 20726902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple-imputation-based residuals and diagnostic plots for joint models of longitudinal and survival outcomes.
    Rizopoulos D; Verbeke G; Molenberghs G
    Biometrics; 2010 Mar; 66(1):20-9. PubMed ID: 19459832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the Subtleties of Inverse Probability Weighting and Marginal Structural Models.
    Breskin A; Cole SR; Westreich D
    Epidemiology; 2018 May; 29(3):352-355. PubMed ID: 29384789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.